Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease
NCT07697547
Crohn Disease, Crohn's Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT Number: NCT01545063
This research aims to give an overview of a number of aspects related to the quality of care for adult patients on home parenteral nutrition.
Concretely this study follows up different aspects on different moments in the care of the patient pathways:
* process indicators concerning indication, parenteral nutrition, training, team access roads and the succession of complications * Outcome indicators * the health-related quality of life * discrepancies in medication use * the role of the different health care providers
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Antwerpen Middelheim, Antwerp, Belgium
Adult patients on HPN will be contacted by phone at three different time moments after their discharge to ask them about indicators, quality of life and discrepancies in medication use. After the follow-up, medical dossiers will be consulted to know which indicators are followed in practice.
The role of the different health care providers will be investigated by face-to-face interviews with different healthcare professionals.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Quality of life will be investigated with the HPN-QoL(r) or FACIT-G (r).
Time frame: 2 years
KU Leuven
Other
Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)
Acronym: CAPANAH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07697547
Crohn Disease, Crohn's Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01155362
Crohn Disease, Crohn's Disease
Los Angeles, California, United States
View Trial DetailsNCT04002180
Crohn Disease, Crohn's Disease
Tokyo, Japan
View Trial DetailsNCT04060303
Colitis, Colitis, Ulcerative
Chicago, Illinois, United States
View Trial Details